Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Róbert Wessman
Person

Róbert Wessman

Tracked across 2 events · 18 articles · First seen Jan 29, 2026 · Last active Mar 31, 2026

Sentiment
30
Attention
4
Events
2
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
4 60
Business
Alvogen Settles Global Eylea Biosimilar Patent Disputes
Róbert Wessman, Chairman and CEO of Alvogen, expressed delight over the resolution of patent matters, highlighting the company's strong position for successful biosimilar launches and its commitment to global healthcare sustainability.
Jan 29, 2026 · 8 articles
2 0
Business
Alvogen Q4 and Full Year 2025 Earnings Release
Róbert Wessman is mentioned as the founder of Alvogen, providing background information about the company's origins.
Mar 04, 2026 · 10 articles
Relationships (3)
Alvogen CEO ↔ Róbert Wessman Róbert Wessman is the Chairman and CEO of Alvogen.
Bayer ↔ Róbert Wessman Unknown
Regeneron Pharmaceuticals ↔ Róbert Wessman Unknown
NEWSDESK
Track Róbert Wessman live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.